Donor cell-derived genetic abnormalities after sex mismatched allogeneic cell transplantation: a unique challenge of donor cell leukemia

Donor cell-derived genetic abnormalities after sex mismatched allogeneic cell transplantation: a unique challenge of donor cell leukemia

Bibliographic Details
Main Authors:	Melanie Klausner, Brian Phan, Laura Morsberger, Rebecca Parish, Alison Shane, Rebecca Park, Christopher D. Gocke, Rena R. Xian, Rick John Jones, Javier Bolaños-Meade, Lukasz P. Gondek, Michael Phan, Ying S. Zou
Format:	Article
Language:	English
Published:	Nature Publishing Group 2023-11-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-023-00938-z

Similar Items

P597: Genetic landscape of donor-derived hematological malignancies and donor-derived clonal abnormalities of uncertain significance after sex mismatched allogeneic stem cell transplantation
by: Melanie Hardy, et al.
Published: (2023-01-01)

Daratumumab for donor-specific anti-HLA antibody desensitization in a case of HLA-mismatched allogeneic stem cell transplantation
by: Uroosa Ibrahim, et al.
Published: (2023-10-01)

Outcomes with mismatched unrelated donor allogeneic hematopoietic stem cell transplantation in adults: A systematic review and meta-analysis
by: Muhammad Umair Mushtaq, et al.
Published: (2022-10-01)

Donor cell-derived myelofibrosis relapse after allogeneic stem cell transplantation
by: Patrizia Chiusolo, et al.
Published: (2022-09-01)

Allogeneic hematopoietic stem cell transplantation for thalassemia major using matched unrelated donors and haploidentical related donors
by: Feiyan Wang, et al.
Published: (2025-02-01)

Severe events in donors after allogeneic hematopoietic stem cell donation
by: Joerg Halter, et al.
Published: (2009-01-01)

Impact of donor marrow cellularity on outcome of allogeneic stem cell transplantation
by: Memoona Khan, et al.
Published: (2023-12-01)

HLA molecular mismatches and induced donor-specific tolerance in combined living donor kidney and hematopoietic stem cell transplantation
by: Aleksandar Senev, et al.
Published: (2024-03-01)

P088: A comprehensive approach to evaluate genetic abnormalities in plasma cell neoplasms using optical genome mapping and next-generation sequencing
by: Ying Zou, et al.
Published: (2024-01-01)

Donor Cell-Derived Myelodysplastic Syndrome Following Allogenic Peripheral Blood Stem Cell Transplant
by: Ujjwala Narang, et al.
Published: (2023-04-01)

Donor Selection for Allogenic Hemopoietic Stem Cell Transplantation: Clinical and Ethical Considerations
by: Irene Riezzo, et al.
Published: (2017-01-01)

Donor and recipient sex in allogeneic stem cell transplantation: what really matters
by: Haesook T. Kim, et al.
Published: (2016-10-01)

Allogenic Hematopoietic Stem Cell Transplantation from Related Donors in Fanconi Anemia
by: Ardeshir Ghavamzadeh, et al.
Published: (2009-03-01)

Allogenic Hematopoietic Stem Cell Transplantation from Related Donors in Fanconi Anemia
by: Amir Ali Hamidieh, et al.
Published: (2009-01-01)

Harnessing allogeneic NK cells: improving outcomes with tailored donor lymphocyte infusion
by: Shannon R. McCurdy
Published: (2022-06-01)

Donor-specific Anti-HLA antibodies in allogeneic hematopoietic stem cell transplantation
by: Sarah Morin-Zorman, et al.
Published: (2016-08-01)

Donor bone marrow-derived T cells inhibit GVHD induced by donor lymphocyte infusion in established mixed allogeneic hematopoietic chimeras.
by: Hui Wang, et al.
Published: (2012-01-01)

Infusion of donor-derived CD8+ memory T cells for relapse following allogeneic hematopoietic cell transplantation
by: Lori Muffly, et al.
Published: (2018-03-01)

Human regulatory T cells of G-CSF mobilized allogeneic stem cell donors qualify for clinical application.
by: Sya N Ukena, et al.
Published: (2012-01-01)

In Vivo Persistence of Donor Cells following Adoptive Transfer of Allogeneic Dendritic Cells in HIV-Infected Patients
by: Michael H. Shapero Ph.D., et al.
Published: (2000-05-01)

DONOR’S BONE MARROW CELLS AS REGULATORS OF IMMUNE TOLERANCE INDUCTION IN RECIPIENT’S OF ALLOGENIC ORGANS
by: N. A. Onishchenko, et al.
Published: (2009-06-01)

Discrimination of Anti-Donor Response in Allogeneic Transplantation Using an Alloreactive T-Cell Detection Assay
by: Ryosuke Arata, et al.
Published: (2025-01-01)

DONOR CHIMERISM IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION
by: V. A. Lavrinenko, et al.
Published: (2018-07-01)

PB2203: AGEING OF LONG-TERM ALLOGENEIC HEMATOPOIETIC CELLS RECIPIENTS COMPARED TO THEIR DONORS
by: M. Czarnogórski, et al.
Published: (2022-06-01)

Searching for the Optimal Donor for Allogenic Adipose-Derived Stem Cells: A Comprehensive Review
by: Tihomir Georgiev-Hristov, et al.
Published: (2022-10-01)

Ageing-resembling phenotype of long-term allogeneic hematopoietic cells recipients compared to their donors
by: Michał Cezary Czarnogórski, et al.
Published: (2022-11-01)

The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Different Donors in Recipients With Mucopolysaccharidosis
by: Yuhua Qu, et al.
Published: (2022-06-01)

Revisiting the Prognostic Influences of Donor-Recipient Size Mismatch in Deceased Donor Liver Transplantation
by: Toshihiro Nakayama, MD, et al.
Published: (2024-11-01)

Mismatched donor cell infusion-related syndrome following microtransplant in patients with acute myeloid leukemia
by: Bo Cai, et al.
Published: (2023-04-01)

Off-the-Shelf Allogeneic T Cell Therapies for Cancer: Opportunities and Challenges Using Naturally Occurring “Universal” Donor T Cells
by: Cynthia Perez, et al.
Published: (2020-11-01)

Donor γδT Cells Promote GVL Effect and Mitigate aGVHD in Allogeneic Hematopoietic Stem Cell Transplantation
by: Yuan Song, et al.
Published: (2020-10-01)

Is It Better to Mobilize Hematopoietic Stem Cells With Pegfilgrastim in Healthy Donors During Allogeneic Hematopoietic Stem Cell Transplantation?
by: Jiali Li, et al.
Published: (2020-09-01)

Panuveitis induced by donor-derived CD8+ T cells after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia
by: Atsunobu Takeda, et al.
Published: (2022-09-01)

Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1
by: Jurjen Versluis, et al.
Published: (2017-02-01)

Immune Reconstitution after Haploidentical Donor and Umbilical Cord Blood Allogeneic Hematopoietic Cell Transplantation
by: Hany Elmariah, et al.
Published: (2021-01-01)

Pediatric allogeneic stem cell transplantation from adult SARS-COV-2 positive donor
by: Shahbaz Memon, et al.
Published: (2023-03-01)

Predictive factors and impact of full donor T-cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation
by: Mohamad Mohty, et al.
Published: (2007-07-01)

True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations—Brief Report
by: Michèle Hoffmann, et al.
Published: (2024-04-01)

Alterations of Peripheral Blood T Cell Subsets following Donor Lymphocyte Infusion in Patients after Allogeneic Stem Cell Transplantation
by: Ann-Kristin Schmaelter, et al.
Published: (2021-11-01)

Combination of Donor Lymphocyte Infusion and Blinatumomab for B-Cell Lymphoblastic Lymphoma Relapse after Allogeneic Stem-Cell Transplantation
by: Jinichi Mori, et al.
Published: (2023-08-01)